Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Covalon Technologies ( (TSE:COV) ) has shared an announcement.
Covalon Technologies will hold its annual shareholder meeting on March 25, 2026, at 2:00 p.m. Eastern Time in a virtual-only format, allowing shareholders to attend and vote online via live webcast. The event will feature a presentation from CEO Brent Ashton followed by a Q&A session, with detailed instructions provided for registered and non-registered shareholders, proxyholders, and guests, underscoring the company’s push for accessible and broad investor participation.
Shareholders must complete specific proxy appointment and registration steps with TSX Trust to vote online, while non-registered holders who do not appoint themselves as proxyholders may attend only as guests. The company has also directed investors to its management information circular, financial statements, and MD&A available on SEDAR+ and its website, reinforcing transparency and ongoing engagement with its investor base ahead of the meeting.
The most recent analyst rating on (TSE:COV) stock is a Buy with a C$2.00 price target. To see the full list of analyst forecasts on Covalon Technologies stock, see the TSE:COV Stock Forecast page.
Spark’s Take on COV Stock
According to Spark, TipRanks’ AI Analyst, COV is a Neutral.
The score is primarily supported by improved profitability versus 2022–2023 and strong TTM cash generation alongside low leverage. It is held back by the recent TTM margin and revenue step-down and a high P/E (~51), while technicals are mixed (shorter-term strength but still below the 200-day trend with slightly negative MACD).
To see Spark’s full report on COV stock, click here.
More about Covalon Technologies
Covalon Technologies Ltd. is a Canadian MedTech company focused on advanced wound care, vascular access, and surgical consumables aimed at improving patient outcomes. Its products are designed to enhance healing, reduce healthcare-associated infections, and protect skin integrity, and the company is listed on the TSX Venture Exchange and trades on the OTCQX Market.
Average Trading Volume: 15,662
Technical Sentiment Signal: Sell
Current Market Cap: C$49.44M
See more data about COV stock on TipRanks’ Stock Analysis page.